Imaging News

A semi-quantitative plain radiographic scoring method for assessing new bone formation in sclerosis and spur in gout is feasible, valid and reproducible, according to data published in Arthritis Research & Therapy.

Imaging should be the preferred choice over palpation in guiding targeted procedures and injections at peripheral and sacroiliac joints, and at structures encompassing peripheral nerves, according to new EULAR “points to consider.”

In patients with non-radiographic axial spondyloarthritis, MRI sacroiliitis and HLA-B27 positivity, but not elevated C-reactive protein or responses at week 12, predict long-term certolizumab pegol response, according to data.

Vascular ultrasound, using high-end equipment and optimized settings, may be an effective replacement for temporal artery biopsy as a first-line diagnostic tool in patients with suspected giant cell arteritis, according to a Danish study.

A newly developed artificial neural network can accurately detect radiographic sacroiliitis in patients with suspected axial spondyloarthritis, according to data presented at ACR Convergence 2021.

The American College of Rheumatology and EULAR have updated classification criteria for five types of large- and small-vessel vasculitis, driven in part by advances in diagnostic imaging, according to presenters at ACR Convergence 2021.

The FDA has granted 510(k) clearance to Siemens Medical Solutions Inc. for the Siemens Naeotom Alpha, a new advancement in diagnostic CT imaging, according to a company press release.

Healio announced the launch of Rheum and Boards, a quiz-based, online learning resource for rheumatologists, according to a Healio press release.

In children who present to the pediatric ED, a point-of-care ultrasonography decision-support algorithm — a rule-in tool — accurately diagnosed transient synovitis, according to data published in JAMA Network Open.

This past spring, two studies shed light on how some of the largest clinician organizations and publishers in rheumatology, including the American College of Rheumatology and EULAR, have failed to provide adequate training materials or clear guidelines when it comes to caring for patients of color.